Genomic Innovator Award (R35 Clinical Trial Optional)

• Outstanding Investigator Award; RFA-HG-18-006
• Deadlines: October 30, 2018; October 30, 2019; October 30, 2020 (Letter of Intent due 45 days prior)
• https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-18-006.html
• This program aims to support researchers to do highly innovative work on important problems in genomics.  The PD/PIs should be creative investigators, early in their careers, who are part of consortia, large research groups, or other team-science efforts.  They should have New Investigator status and have shown the potential to make important contributions to the field of genomics.  PD/PIs will have flexibility to take their research in novel directions as scientific opportunities arise during this award.

U.S. – India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed)

• PAR-18-912
• Deadlines: November 8, 2018; November 8, 2019; November 9, 2020
• https://grants.nih.gov/grants/guide/pa-files/PAR-18-912.html
• This FOA is intended to support collaborations between the U.S. and India that focus on the basic biology, epigenetic, and/or genetics of ophthalmic diseases and visual disorders.
• Applications may include, but are not limited to collaborations addressing the following areas:
  • Family based genome wide association studies (GWAS) on available cohorts of consanguineous families from India to identify genetic variants that predispose to both Mendelian and complex forms of eye disease;
  • Validation of novel GWAS findings in appropriate animal models;
  • Identification of biomarkers that predict and/or assess risk and response to interventions;
  • Studies of environmental factors that predict risk of eye diseases such as imprinting and other epigenetic effects;
  • Studies to determine the underlying biology of ocular diseases including, AMD, diabetic retinopathy, glaucoma, retinitis pigmentosa, cataracts, myopia and presbyopia;
  • Studies focusing on the basic science of neuroplasticity of vision including perceptual learning and adaptation after eye injury;
  • Studies of the mechanisms through which environmental pollutants/toxins contribute to ocular diseases and their complications including infection and inflammation;
  • Identification of factors that influence the success of corneal transplantation and recovery after surgery.